Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment
Keywords: α-SMA; α-smooth muscle actin; AMPK; AMP-activated protein kinase; bHLH; basic Helix-Loop-Helix; DHA; docosahexaenoic acid (22:6n-3); Drp1; dynamin-related protein 1; ECM; extracellular matrix; EMT; epithelial-to-mesenchymal transition; EPA; eicosapentae